Rana McKay, MD, deliberates on patient types appropriate to receive a TKI in the treatment of RCC

Dr. McKay, Assistant Professor of Medicine, UCSD, deliberates on the patient types most appropriate to receive a TKI in the treatment of 1st line renal cell carcinoma patients

asco gu,gu20,obr,obroncology,renal cell carcinoma,RCC,